466 related articles for article (PubMed ID: 31957152)
1. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
Van Neste D
Skin Res Technol; 2020 Jul; 26(4):542-557. PubMed ID: 31957152
[TBL] [Abstract][Full Text] [Related]
2. Viable terminal scalp hair follicles constitute a necessary and sufficient biological end-organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles.
Van Neste D
Skin Res Technol; 2019 Sep; 25(5):701-711. PubMed ID: 31206839
[TBL] [Abstract][Full Text] [Related]
3. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride.
Van Neste D
Skin Pharmacol Physiol; 2006; 19(3):168-76. PubMed ID: 16679818
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a "drug dependency" and a post-finasteride "rebound effect".
Van Neste D
Skin Res Technol; 2019 Sep; 25(5):712-719. PubMed ID: 31081179
[TBL] [Abstract][Full Text] [Related]
5. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
6. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A; Godwin M
J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
[TBL] [Abstract][Full Text] [Related]
8. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
11. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
Gupta AK; Talukder M
J Cosmet Dermatol; 2022 May; 21(5):1841-1848. PubMed ID: 35238144
[TBL] [Abstract][Full Text] [Related]
12. What's New in Therapy for Male Androgenetic Alopecia?
Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
[TBL] [Abstract][Full Text] [Related]
13. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Manabe M; Tsuboi R; Itami S; Osada SI; Amoh Y; Ito T; Inui S; Ueki R; Ohyama M; Kurata S; Kono T; Saito N; Sato A; Shimomura Y; Nakamura M; Narusawa H; Yamazaki M;
J Dermatol; 2018 Sep; 45(9):1031-1043. PubMed ID: 29863806
[TBL] [Abstract][Full Text] [Related]
15. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK; Talukder M; Williams G
J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
Rossi A; Caro G
J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
Gupta AK; Talukder M; Shemer A
Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
[TBL] [Abstract][Full Text] [Related]
19. Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride.
Chandrashekar BS; Nandhini T; Vasanth V; Sriram R; Navale S
Indian Dermatol Online J; 2015; 6(1):17-20. PubMed ID: 25657911
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Hossein Mostafa D; Samadi A; Niknam S; Nasrollahi SA; Guishard A; Firooz A
J Pharm Pharm Sci; 2021; 24():191-199. PubMed ID: 33909554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
